Adverse events180

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 180

Type	Event	Organ system	Group	Affected	At risk
other	Nausea	Gastrointestinal disorders	Pre-Treatment Phase (Intake Visit & Clinic 1): Extended Run-In Group	13	163
other	Nausea	Gastrointestinal disorders	Pre-Treatment Phase (Intake Visit & Clinic 1): Standard Run-In Group	13	157
other	Nausea	Gastrointestinal disorders	Pre-Quit Run-In Manip Phase (Clinic 2 & 3): Extended Run-In Group	45	157
other	Nausea	Gastrointestinal disorders	Pre-Quit Run-In Manip Phase (Clinic 2 & 3): Standard Run-In Group	26	147
other	Nausea	Gastrointestinal disorders	Early Quit Phase (Clinic 4 & 5): Extended Run-In Group	48	150
other	Nausea	Gastrointestinal disorders	Early Quit Phase (Clinic 4 & 5): Standard Run-In Group	42	146
other	Vomiting	Gastrointestinal disorders	Pre-Treatment Phase (Intake Visit & Clinic 1): Extended Run-In Group	1	163
other	Vomiting	Gastrointestinal disorders	Pre-Treatment Phase (Intake Visit & Clinic 1): Standard Run-In Group	2	157
other	Vomiting	Gastrointestinal disorders	Pre-Quit Run-In Manip Phase (Clinic 2 & 3): Extended Run-In Group	11	157
other	Vomiting	Gastrointestinal disorders	Pre-Quit Run-In Manip Phase (Clinic 2 & 3): Standard Run-In Group	5	147
other	Vomiting	Gastrointestinal disorders	Early Quit Phase (Clinic 4 & 5): Extended Run-In Group	10	150
other	Vomiting	Gastrointestinal disorders	Early Quit Phase (Clinic 4 & 5): Standard Run-In Group	9	146
other	Abdominal Pain	Gastrointestinal disorders	Pre-Treatment Phase (Intake Visit & Clinic 1): Extended Run-In Group	8	163
other	Abdominal Pain	Gastrointestinal disorders	Pre-Treatment Phase (Intake Visit & Clinic 1): Standard Run-In Group	9	157
other	Abdominal Pain	Gastrointestinal disorders	Pre-Quit Run-In Manip Phase (Clinic 2 & 3): Extended Run-In Group	19	157
other	Abdominal Pain	Gastrointestinal disorders	Pre-Quit Run-In Manip Phase (Clinic 2 & 3): Standard Run-In Group	8	147
other	Abdominal Pain	Gastrointestinal disorders	Early Quit Phase (Clinic 4 & 5): Extended Run-In Group	13	150
other	Abdominal Pain	Gastrointestinal disorders	Early Quit Phase (Clinic 4 & 5): Standard Run-In Group	12	146
other	Indigestion	Gastrointestinal disorders	Pre-Treatment Phase (Intake Visit & Clinic 1): Extended Run-In Group	17	163
other	Indigestion	Gastrointestinal disorders	Pre-Treatment Phase (Intake Visit & Clinic 1): Standard Run-In Group	13	157

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03262662/events

API reference For AI assistants

Adverse events180

Sources 3

Read this list from software.